ANKRD49 promotes the metastasis of NSCLC via activating JNK-ATF2/c-Jun-MMP-2/9 axis

Jia Sun1,2, Jin-Rui Hu3, Chao-Feng Liu1

  • 1Department of Pulmonary and Critical Care Medicine, Shanxi Province Key Laboratory of Respiratory Disease, the First Hospital, Shanxi Medical University, NHC Key Laboratory of Pneumoconiosis, Taiyuan, Shanxi, 030001, China.

BMC Cancer
|November 14, 2023
PubMed
Abstract

Insights

Ankyrin repeat domain 49 (ANKRD49) promotes non-small cell lung cancer (NSCLC) invasion and metastasis by activating JNK signaling, which upregulates MMP-2/MMP-9 expression through c-Jun and ATF2. This study clarifies ANKRD49

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Ankyrin repeat domain 49 (ANKRD49) is highly expressed in lung adenocarcinoma (LUAD) and lung squamous carcinoma (LUSC).
  • The precise role of ANKRD49 in non-small cell lung cancer (NSCLC) pathogenesis remains unclear.
  • Previous studies suggested ANKRD49 promotes LUAD cell invasion via the p38-ATF-2-MMP2/MMP9 pathway.

Purpose of the Study:

  • To investigate the function and mechanism of ANKRD49 in NSCLC using various cell lines.
  • To elucidate the signaling pathways and molecular targets regulated by ANKRD49 in NSCLC.
  • To validate the role of ANKRD49 in NSCLC tumorigenicity and metastasis in vivo.

Main Methods:

  • Real-time qPCR to assess ANKRD49 expression in NSCLC tissues and adjacent normal tissues.
  • In vitro assays (overexpression, RNA interference, gelatin zymography, CCK-8, colony formation, wound healing, migration, invasion) in NCI-H1299 and NCI-H1703 cells.
  • Immunoprecipitation, chromatin immunoprecipitation, and nude mouse models to analyze molecular interactions, transcriptional regulation, and tumorigenicity.

Main Results:

  • ANKRD49 expression is significantly higher in NSCLC tissues compared to normal tissues.
  • ANKRD49 overexpression enhances migration and invasion in NSCLC cells by increasing MMP-2 and MMP-9 levels.
  • ANKRD49 activates the JNK pathway, leading to c-Jun and ATF2 phosphorylation and subsequent transcriptional activation of MMP-2/MMP-9 promoters.

Conclusions:

  • ANKRD49 promotes NSCLC cell invasion and metastasis through JNK-mediated transcriptional activation of MMP-2/MMP-9 via c-Jun and ATF2.
  • The identified molecular mechanism differs from previously reported pathways in A549 cells, highlighting NSCLC heterogeneity.
  • This study provides a comprehensive understanding of ANKRD49's role in NSCLC progression and metastasis.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.6K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
2.7K